Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has promoted Mark Ubert, MBA, to the position of Chief Financial Officer (CFO). As CFO, Mark will provide financial and strategic leadership to the growing organization, exemplified in the role he played in Rho’s acquisition of European CRO Dokumeds. Mark brings more than 30 years of experience to the role of Chief Financial Officer. He joined Rho in March of 2020 as VP of Finance.

Jan 28, 2022, 17:23 by

Dolomite Bio has announced the launch of a Bioinformatics Service which can be purchased alongside the recently launched RNAdia kit for single-cell research.

Jan 28, 2022, 17:23 by

Great Lakes Clinical Trials and Clinical Site Partners join Excel Medical Clinical Trials and platform site Clinical Trials of Texas at Flourish Research, expanding capabilities to 60 indications.

Jan 28, 2022, 17:23 by

ZEISS LSM Plus and ZEISS Airyscan Joint Deconvolution introduced

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological significance of microarray data and, at the same time, help reduce the time and cost of wet laboratory experiments and data generation.

Jan 28, 2022, 17:23 by

The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment.

Jan 28, 2022, 17:23 by

This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies.

Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering away at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company recently announced the launch of ligand-based pharmacophore model service for scientists to accelerate the drug candidate development process.

Jan 28, 2022, 17:23 by

Lipidomics, a division of Creative Proteomics, is committed to providing untargeted lipidomics services, targeted lipidomics services, metabolic flux analysis services, and lipidomics related services for research institutions, biotechnology and pharmaceutical companies. The company continues to accelerate lipidomics research to make contributions in the fields of biopharmaceuticals, population health, the food industry, etc. Creative Proteomics Lipidomics has recently announced the launch of Exosomes Lipidomics Service, which can help scientists understand vesicle biogenesis and function, identify lipid-based biomarkers and unravel their monitoring function in diseases.